Kobi Iki
Directeur Technique/Scientifique/R&D chez BAROnova, Inc.
Profil
Kobi Iki is currently the Vice President-Research & Development at BAROnova, Inc. and the Chief Operating Officer at Gravitas Medical, Inc. Previously, he held positions as Principal at Miravant Medical Technologies, ORATEC Interventions, Inc., and Wallace Enterprises, Inc. He also served as the Vice President-Research at Leptos Biomedical, Inc.
Postes actifs de Kobi Iki
| Sociétés | Poste | Début |
|---|---|---|
BAROnova, Inc.
 BAROnova, Inc. Medical DistributorsDistribution Services BAROnova, Inc. operates as a clinical-stage medical-device company. It develops nonsurgical, nonpharmacologic devices. The firm's TransPyloric Shuttle device enables the patient' stomach to fill up faster, stay full longer, and potentially delay gastric emptying. The company was founded by Hugh Narciso in 2006 and is headquartered in Goleta, CA. | Directeur Technique/Scientifique/R&D | - |
Gravitas Medical, Inc.
 Gravitas Medical, Inc. Medical SpecialtiesHealth Technology Gravitas Medical, Inc. is a medical device company based in Silicon Valley, CA. The American company is committed to transforming enteral feeding into enteral nutrition intelligence by using technology to provide actionable insights for caregivers. Gravitas Medical aims to revolutionize the field of gut-related information. The private company was founded by Daniel Burnett and Saheel Sutaria. | Directeur des opérations | - |
Anciens postes connus de Kobi Iki
| Sociétés | Poste | Fin |
|---|---|---|
Leptos Biomedical, Inc.
 Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. They believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use. | Directeur Technique/Scientifique/R&D | 12/11/2010 |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Corporate Officer/Principal | - |
ORATEC Interventions, Inc.
 ORATEC Interventions, Inc. Medical SpecialtiesHealth Technology ORATEC Interventions, Inc. develops and markets medical devices that use controlled thermal energy to treat spine and joint disorders. The company markets two minimally invasive systems: the SpineCATH IntraDiscal ElectroThermal Therapy (IDET) system and the ElectroThermal Arthroscopy system. The company markets its products directly to orthopedic surgeons, neurosurgeons and pain management specialists. | Corporate Officer/Principal | - |
Wallace Enterprises, Inc.
 Wallace Enterprises, Inc. Medical SpecialtiesHealth Technology Wallace Enterprises, Inc. develops, manufactures and markets devices for treating peripheral vascular disease and nonvascular obstructions. The company was founded by Thomas J. Fogarty in 1997 and is headquartered in Nashville, TN. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Leptos Biomedical, Inc.
Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. They believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use. | Health Technology |
BAROnova, Inc.
BAROnova, Inc. Medical DistributorsDistribution Services BAROnova, Inc. operates as a clinical-stage medical-device company. It develops nonsurgical, nonpharmacologic devices. The firm's TransPyloric Shuttle device enables the patient' stomach to fill up faster, stay full longer, and potentially delay gastric emptying. The company was founded by Hugh Narciso in 2006 and is headquartered in Goleta, CA. | Distribution Services |
Wallace Enterprises, Inc.
Wallace Enterprises, Inc. Medical SpecialtiesHealth Technology Wallace Enterprises, Inc. develops, manufactures and markets devices for treating peripheral vascular disease and nonvascular obstructions. The company was founded by Thomas J. Fogarty in 1997 and is headquartered in Nashville, TN. | Health Technology |
ORATEC Interventions, Inc.
ORATEC Interventions, Inc. Medical SpecialtiesHealth Technology ORATEC Interventions, Inc. develops and markets medical devices that use controlled thermal energy to treat spine and joint disorders. The company markets two minimally invasive systems: the SpineCATH IntraDiscal ElectroThermal Therapy (IDET) system and the ElectroThermal Arthroscopy system. The company markets its products directly to orthopedic surgeons, neurosurgeons and pain management specialists. | Health Technology |
Gravitas Medical, Inc.
Gravitas Medical, Inc. Medical SpecialtiesHealth Technology Gravitas Medical, Inc. is a medical device company based in Silicon Valley, CA. The American company is committed to transforming enteral feeding into enteral nutrition intelligence by using technology to provide actionable insights for caregivers. Gravitas Medical aims to revolutionize the field of gut-related information. The private company was founded by Daniel Burnett and Saheel Sutaria. | Health Technology |